SCHEMBL4804462

SCHEMBL4804462

CCOC(=O)CCCn1c(=O)n(C2CCN(C(=O)O)[C@@H](CCCN(Cc3ccccc3)Cc3ccccc3)C2)c2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CACNA1G O43497 4/20 0.43
▸ CACNA1H O95180 4/20 0.43
▸ OPRM1 P35372 4/20 0.42
▸ TACR1 P25103 1/20 0.42
▸ TNF P01375 2/20 0.40
▸ CYP3A4 P08684 2/20 0.38
▸ CYP2D6 P10635 2/20 0.37
▸ OPRL1 P41146 3/20 0.37
▸ C5AR1 P21730 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ OPRD1 P41143 2/20 0.35
▸ OPRK1 P41145 2/20 0.35
▸ GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3808654 0.90 OPRM1 (0.41) CACNA1GCACNA1HOPRM1TACR1TNF
SCHEMBL4804471 0.86 CACNA1G (0.43) CACNA1GCACNA1HOPRM1TACR1TNF
SCHEMBL4804476 0.86 CACNA1G (0.43) CACNA1GCACNA1HOPRM1TACR1TNF
SCHEMBL4675598 0.84 CYP3A4 (0.40) CACNA1GCACNA1HOPRM1CYP3A4CYP2D6
SCHEMBL3670916 0.83 CHRM2 (0.38) CACNA1GCACNA1HOPRM1CYP2D6OPRL1
SCHEMBL4804451 0.82 CACNA1G (0.43) CACNA1GCACNA1HOPRM1TACR1TNF
SCHEMBL4681959 0.81 OPRL1 (0.44) CACNA1GCACNA1HOPRM1CYP3A4CYP2D6
SCHEMBL3665332 0.79 POLB (0.35) CACNA1GCACNA1HOPRM1OPRL1C5AR1
SCHEMBL3799851 0.79 OPRL1 (0.42) CACNA1GCACNA1HOPRM1CYP3A4CYP2D6
SCHEMBL3398375 0.78 CACNA1G (0.35) CACNA1GCACNA1HCYP3A4CYP2D6C5AR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1997805-A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans Commissariat à l'Energie Atomique (FR) 2008-12-03 — — EP disclosed
Send feedback